Balentine LLC Idexx Laboratories Inc Transaction History

Balentine LLC

$2.23 Billion
Q1 2025

A detailed history of Balentine LLC transactions in Idexx Laboratories Inc stock. As of the latest transaction made, Balentine LLC holds 1,571 shares of IDXX stock, worth $813,935. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,571

Holding current value

$813,935

% of portfolio

0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$406.29 - $469.04 $638,281 - $736,861	1,571 New	1,571 $659,000
Q1 2024 May 15, 2024	BUY	$515.08 - $576.87 $398,156 - $445,920	773 Added 45.52%	2,471 $1.33 Million
Q4 2023 Feb 09, 2024	BUY	$391.37 - $557.56 $94,711 - $134,929	242 Added 16.62%	1,698 $942,000
Q3 2023 Nov 13, 2023	BUY	$432.42 - $556.67 $13,837 - $17,813	32 Added 2.25%	1,456 $636,000
Q2 2023 Aug 14, 2023	BUY	$450.7 - $503.61 $23,436 - $26,187	52 Added 3.79%	1,424 $715,000
Q1 2023 May 11, 2023	BUY	$406.01 - $514.59 $4,872 - $6,175	12 Added 0.88%	1,372 $686,000
Q4 2022 Jan 31, 2023	BUY	$324.64 - $441.27 $63,304 - $86,047	195 Added 16.74%	1,360 $554,000
Q3 2022 Oct 26, 2022	SELL	$325.8 - $407.78 $32,254 - $40,370	-99 Reduced 7.83%	1,165 $380,000
Q2 2022 Oct 26, 2022	BUY	$327.37 - $553.44 $49,105 - $83,016	150 Added 13.46%	1,264 $443,000
Q2 2022 Aug 15, 2022	BUY	$327.37 - $553.44 $49,105 - $83,016	150 Added 13.46%	1,264 $443,000
Q1 2022 Oct 26, 2022	SELL	$466.52 - $631.01 $69,978 - $94,651	-150 Reduced 11.87%	1,114 $609,000
Q1 2022 May 06, 2022	BUY	$466.52 - $631.01 $150,219 - $203,185	322 Added 40.66%	1,114 $609,000
Q4 2021 Oct 26, 2022	SELL	$586.54 - $666.48 $276,846 - $314,578	-472 Reduced 37.34%	792 $522,000
Q4 2021 Feb 02, 2022	BUY	$586.54 - $666.48 $38,711 - $43,987	66 Added 9.09%	792 $522,000
Q3 2021 Nov 15, 2021	BUY	$621.9 - $705.76 $26,741 - $30,347	43 Added 6.3%	726 $451,000
Q2 2021 Aug 16, 2021	BUY	$486.36 - $637.08 $40,367 - $52,877	83 Added 13.83%	683 $431,000
Q4 2020 Feb 08, 2021	SELL	$383.85 - $499.87 $4,222 - $5,498	-11 Reduced 1.8%	600 $300,000
Q3 2020 Nov 02, 2020	SELL	$334.54 - $406.31 $6,690 - $8,126	-20 Reduced 3.17%	611 $240,000
Q2 2020 Aug 14, 2020	BUY	$230.66 - $330.16 $2,075 - $2,971	9 Added 1.45%	631 $208,000
Q1 2020 May 18, 2020	SELL	$182.94 - $290.97 $28,355 - $45,100	-155 Reduced 19.95%	622 $151,000
Q4 2019 Sep 02, 2020	SELL	$248.66 - $285.01 $677,847 - $776,937	-2,726 Reduced 77.82%	777 $203,000
Q3 2019 Nov 15, 2019	SELL	$260.07 - $289.93 $6,241 - $6,958	-24 Reduced 0.68%	3,503 $953,000
Q2 2019 Aug 14, 2019	SELL	$215.53 - $275.33 $4,310 - $5,506	-20 Reduced 0.56%	3,527 $971,000
Q1 2019 May 16, 2019	SELL	$178.02 - $225.69 $14,597 - $18,506	-82 Reduced 2.26%	3,547 $796,000
Q4 2018 Feb 13, 2019	BUY	$176.18 - $248.92 $466,348 - $658,891	2,647 Added 269.55%	3,629 $675,000
Q3 2018 Nov 14, 2018	BUY	$218.82 - $254.46 $214,881 - $249,879	982 New	982 $245,000
Q1 2018 May 16, 2018	SELL	$157.81 - $204.73 $488,264 - $633,434	-3,094 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$150.32 - $166.46 $465,090 - $515,027	3,094	3,094 $481,000

Others Institutions Holding IDXX

# of Institutions

1,259

Shares Held

76M

Call Options Held

129K

Put Options Held

219K

Vanguard Group Inc Valley Forge, PA

9.86M
Shares

$5.11 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

9.6M
Shares

$4.98 Billion
0.11% of portfolio
State Street Corp Boston, MA

3.65M
Shares

$1.89 Billion
0.06% of portfolio
Terry Smith Fundsmith LLP | London, X0

2.65M
Shares

$1.37 Billion
5.14% of portfolio
Geode Capital Management, LLC Boston, MA

2.41M
Shares

$1.25 Billion
0.08% of portfolio

View Full List

About IDEXX LABORATORIES INC

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $43.1B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

More about IDXX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account